Gen-Wealth Partners’s GSK GSK Stock Holding History

Gen-Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.72K	Hold	90	–	–	﹤0.01%	598
2026 Q1	$4.97K	Hold	90	–	–	﹤0.01%	591
2025 Q4	$4.41K	Hold	90	–	–	﹤0.01%	575
2025 Q3	$3.88K	Hold	90	–	–	﹤0.01%	582
2025 Q2	$3.46K	Hold	90	–	–	﹤0.01%	539
2025 Q1	$3.49K	Hold	90	–	–	﹤0.01%	525
2024 Q4	$3.04K	Hold	90	–	–	﹤0.01%	560
2024 Q3	$3.33K	Hold	90	–	–	﹤0.01%	575
2024 Q2	$3.46K	Hold	90	–	–	﹤0.01%	553
2024 Q1	$3.86K	Buy	+90	New	+$3.71K	﹤0.01%	534

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gen-Wealth Partners's GSK Position: Q2 2026 in Review

Gen-Wealth Partners held its GSK (GSK) position steady in Q2 2026 at 90 shares worth $4.72K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Gen-Wealth Partners first reported a position in GSK in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.97K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Gen-Wealth Partners held 90 shares of GSK worth $4.72K as of Q2 2026.
Gen-Wealth Partners left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q2 2026, its #598 holding.
Gen-Wealth Partners first reported a position in GSK in Q1 2024 and has held it in 10 quarters since.
Gen-Wealth Partners's GSK position peaked at $4.97K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.